First trimester screening is a combination of fetal ultrasound and maternal blood testing. It can help find out the risk that the fetus has certain birth defects. Screening tests may be used alone or with other tests.
First trimester screening has three parts.
Ultrasound test for fetal nuchal translucency (NT)
Nuchal translucency screening uses an ultrasound test to check the area at the back of the fetal neck for extra fluid or thickening.
Two maternal serum (blood) tests
These tests measure two substances found in the blood of all pregnant people:
- Pregnancy-associated plasma protein screening (PAPP-A). This is a protein made by the placenta in early pregnancy. Abnormal levels are linked to a higher risk for chromosome problems.
- Human chorionic gonadotropin (hCG). This is a hormone made by the placenta in early pregnancy. Abnormal levels are linked to a higher risk for chromosome problems.
When used together, these tests have a greater ability to find out if the fetus might have a genetic birth defect, such as Down syndrome (trisomy 21) and trisomy 18.
If the results of these tests are abnormal, your doctor will suggest genetic counseling. You may need more testing. That may include chorionic villus sampling, amniocentesis, cell-free fetal DNA, or other ultrasounds.